INCY

Incyte
INCY

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$11.69B
EV
$9.32B
Shares Outstanding
193.52M
Beta
0.90

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$73.48
P/E 2025E
10.47x
P/Revenue 2025E
2.50x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Incyte Corporation

gainify
INCY

Incyte Corporation

INCY

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxoliti...

Sector

Healthcare

Industry

Biotechnology

CEO

Hoppenot, Herve

Employees

2,617

IPO Date

1993-11-04

Headquarters

1801 Augustine Cut-Off, Wilmington, Delaware, 19803, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved